RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 34 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,371,906 | +28.9% | 1,493,356 | +11.0% | 0.01% | +50.0% |
| Q2 2023 | $8,824,151 | +262.0% | 1,345,145 | +230.0% | 0.00% | +300.0% |
| Q1 2023 | $2,437,478 | +156.7% | 407,605 | 0.0% | 0.00% | – |
| Q4 2022 | $949,720 | -30.4% | 407,605 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,365,000 | +26.4% | 407,605 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,080,000 | -10.1% | 407,605 | -0.2% | 0.00% | – |
| Q1 2022 | $1,201,000 | -68.8% | 408,506 | -9.2% | 0.00% | -100.0% |
| Q4 2021 | $3,848,000 | +14.8% | 450,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $3,353,000 | -28.1% | 450,000 | -10.0% | 0.00% | -50.0% |
| Q2 2021 | $4,665,000 | – | 500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $6,384,000 | 9.38% |
| Abingworth LLP | 2,073,957 | $5,413,000 | 1.73% |
| Aisling Capital Management LP | 886,075 | $2,348,000 | 1.68% |
| NEA Management Company, LLC | 4,786,921 | $12,685,000 | 0.65% |
| Novo Holdings A/S | 3,430,377 | $9,090,000 | 0.45% |
| Ikarian Capital, LLC | 185,597 | $491,000 | 0.09% |
| Rock Springs Capital Management LP | 1,143,185 | $3,029,000 | 0.09% |
| Newtyn Management, LLC | 20,983 | $56,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $186,000 | 0.00% |
| Ergoteles LLC | 42,400 | $112,000 | 0.00% |